Careers  |  Sign In  |  Register  |   Twitter

Achillion, Gilead Drug Synthesis Cures Hep C in Six Weeks

According to Reuters, a new experimental hepatitis C drug from Achillion Pharmaceuticals can cure the infection in just six weeks when used with Gilead SciencesSovaldi. Currently, Gilead’s Harvoni and AbbVie’s Viekira Pak are the top treatment options available, offering a cure in 8 and 12 weeks, respectively. Four and six-week treatment evaluations will be conducted on the new experimental combination from Achillion, which if successful, will challenge Gilead and AbbVie in the multi-billion dollar market.

Read the article published by Reuters.